131 related articles for article (PubMed ID: 8600679)
1. [Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes].
Seelentag WK; Flury R; Schmid M; Komminoth P; Saremaslani P; Günthert U; Heitz PU; Roth J
Verh Dtsch Ges Pathol; 1995; 79():144-7. PubMed ID: 8600679
[TBL] [Abstract][Full Text] [Related]
2. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation.
Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J
Int J Cancer; 1996 Jun; 69(3):218-24. PubMed ID: 8682591
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
4. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis.
Kasper M; Günthert U; Dall P; Kayser K; Schuh D; Haroske G; Müller M
Am J Respir Cell Mol Biol; 1995 Dec; 13(6):648-56. PubMed ID: 7576702
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
Ashida K; Terada T; Kitamura Y; Kaibara N
Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study.
Washington K; Telen MJ; Gottfried MR
Liver; 1997 Feb; 17(1):17-23. PubMed ID: 9062875
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
[TBL] [Abstract][Full Text] [Related]
8. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
10. CD44 standard and variant isoform expression in normal human skin appendages and epidermis.
Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J
Histochem Cell Biol; 1996 Sep; 106(3):283-9. PubMed ID: 8897069
[TBL] [Abstract][Full Text] [Related]
11. Detection of CD44 splice variants in formalin-fixed, paraffin-embedded specimens of human skin cancer.
Dietrich A; Tanczos E; Vanscheidt W; Schöpf E; Simon JC
J Cutan Pathol; 1997 Jan; 24(1):37-42. PubMed ID: 9027631
[TBL] [Abstract][Full Text] [Related]
12. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
Fichtner I; Dehmel A; Naundorf H; Finke LH
Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
[TBL] [Abstract][Full Text] [Related]
14. Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.
Bànkfalvi A; Terpe HJ; Breukelmann D; Bier B; Rempe D; Pschadka G; Krech R; Böcker W
Histopathology; 1998 Aug; 33(2):107-16. PubMed ID: 9762542
[TBL] [Abstract][Full Text] [Related]
15. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival.
Endo K; Terada T
J Hepatol; 2000 Jan; 32(1):78-84. PubMed ID: 10673070
[TBL] [Abstract][Full Text] [Related]
16. CD44 is expressed in hepatocellular carcinomas showing vascular invasion.
Mathew J; Hines JE; Obafunwa JO; Burr AW; Toole K; Burt AD
J Pathol; 1996 May; 179(1):74-9. PubMed ID: 8691349
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component.
Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Itoi N; Tomida K; Tanaka A; Sakai S; Kitamura M; Kubota Y; Kushima R; Tani M
Breast Cancer; 2016 Nov; 23(6):869-875. PubMed ID: 26494575
[TBL] [Abstract][Full Text] [Related]
20. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]